Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy
- PMID: 17623561
Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy
Abstract
Cigarette smoking is one of the most important risk factors for burden of disease. Our objective was to estimate the smoking-attributable deaths and the years of life lost for Canada 2002. For Canada in 2002, 37,209 of all deaths aged 0 to 80+ years were attributable to smoking, 23,766 in men and 13,443 in women. This constituted 16.6 percent of all deaths in Canada, 21 percent for men and 12.2 percent for women. Main causes of smoking-attributable death were malignant neoplasms (17,427), cardiovascular diseases (CVD) (10,275) and respiratory diseases (8,282). Lung cancer (13,401) and chronic obstructive pulmonary disease (COPD) (7,533) were the single largest disease contributors to deaths caused by smoking. 515,608 years of life were lost prematurely in Canada in that year, 316,417 years in men and 199,191 years in women. Cigarette smoking is a major contributor to mortality in Canada and its impact on Canadian society continues to be an unacceptable burden.
Similar articles
-
Alcohol-attributable mortality and potential years of life lost in Canada 2001: implications for prevention and policy.Addiction. 2006 Mar;101(3):373-84. doi: 10.1111/j.1360-0443.2005.01338.x. Addiction. 2006. PMID: 16499510
-
Risk factors for cardiovascular disease in Canada.Can J Cardiol. 2003 Oct;19(11):1249-59. Can J Cardiol. 2003. PMID: 14571310
-
Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.Tob Control. 2006 Dec;15(6):464-71. doi: 10.1136/tc.2006.016030. Tob Control. 2006. PMID: 17130376 Free PMC article.
-
Prevention of smoking-related deaths in the United States.Am J Prev Med. 2004 Aug;27(2):118-25. doi: 10.1016/j.amepre.2004.04.014. Am J Prev Med. 2004. PMID: 15261898 Review.
-
Modelling the health benefits of smoking cessation in Japan.Tob Control. 2009 Feb;18(1):10-7. doi: 10.1136/tc.2007.024620. Epub 2008 Aug 26. Tob Control. 2009. PMID: 18728096 Review.
Cited by
-
Smokers' support for tobacco endgame measures in Canada: findings from the 2016 International Tobacco Control Smoking and Vaping Survey.CMAJ Open. 2018 Sep 28;6(3):E412-E422. doi: 10.9778/cmajo.20180025. Print 2018 Jul-Sep. CMAJ Open. 2018. PMID: 30266779 Free PMC article.
-
Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.Can J Psychiatry. 2017 Sep;62(9):624-634. doi: 10.1177/0706743717720196. Can J Psychiatry. 2017. PMID: 28886671 Free PMC article. Review.
-
Effect of interactions between LEPR polymorphisms and smoking on coronary artery disease susceptibility.Int J Clin Exp Pathol. 2017 Sep 1;10(9):9753-9759. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966858 Free PMC article.
-
Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period.Can J Public Health. 2007 May-Jun;98(3):228-34. doi: 10.1007/BF03403718. Can J Public Health. 2007. PMID: 17626390 Free PMC article.
-
Impact of marginalization on tobacco use in individuals diagnosed with head and neck Cancer.J Otolaryngol Head Neck Surg. 2019 Oct 24;48(1):54. doi: 10.1186/s40463-019-0380-5. J Otolaryngol Head Neck Surg. 2019. PMID: 31651374 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical